Guangzhou Magpie Pharmaceuticals Co., Ltd.
Clinical trials sponsored by Guangzhou Magpie Pharmaceuticals Co., Ltd., explained in plain language.
-
Experimental blood pressure drug put to the test in healthy volunteers
Disease control Not yet recruitingResearchers are testing an experimental oral drug called MN-08 in healthy adults to see how safe and tolerable it is. The trial gives participants either MN-08 or a placebo for about a week and measures side effects, vital signs, heart rhythm, and blood test changes. It also trac…
Phase 1 • Sponsor: Guangzhou Magpie Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Experimental tablet TBN put to the test in healthy volunteers
Knowledge-focused Not yet recruitingResearchers are running a phase 1 trial to see how safe and tolerable multiple doses of an experimental tablet called TBN are in healthy adults. Sixteen participants will take TBN or a placebo twice a day for six days, plus a final morning dose on day seven. The study also measur…
Phase 1 • Sponsor: Guangzhou Magpie Pharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated Sep 13, 2026 00:00 UTC